XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Condensed Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 141,805 $ 138,052
Receivables 84,020 76,651
Inventories:    
Finished goods 31,216 31,350
Work in process 35,565 23,577
Raw materials 77,968 64,929
Total inventories 144,749 119,856
Prepaid expenses and other current assets 18,013 13,273
Total current assets 388,587 347,832
Property, plant and equipment, at cost 227,775 220,945
Less accumulated depreciation (153,069) (147,403)
Net property, plant and equipment 74,706 73,542
Intangible assets, at cost less accumulated amortization 57,512 53,607
Other assets 11,849 14,048
Deferred income taxes 12,801 12,757
Goodwill 113,797 101,261
Total assets 659,252 603,047
Current liabilities:    
Payables 81,104 71,440
Accrued compensation and employee benefits 17,491 20,513
Warranty and after-sale costs 11,045 9,606
Other current liabilities 9,274 8,753
Total current liabilities 118,914 110,312
Other long-term liabilities 49,431 37,808
Deferred income taxes 6,661 4,648
Accrued non-pension postretirement benefits 3,612 3,917
Other accrued employee benefits 5,042 3,940
Commitments and contingencies (Note 5)
Shareholders’ equity:    
Common stock: $1 par value; 80,000,000 and 40,000,000 shares authorized in 2023 and 2022, respectively; 37,221,098 shares issued in 2023 and 2022 37,221 37,221
Capital in excess of par value 55,833 53,282
Reinvested earnings 423,877 395,155
Accumulated other comprehensive loss (4,203) (5,983)
Less: Treasury stock, at cost, 7,903,197 shares in 2023 and 7,928,071 shares in 2022 (37,136) (37,253)
Total shareholders’ equity 475,592 442,422
Total liabilities and shareholders’ equity $ 659,252 $ 603,047